NO963254D0 - Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler - Google Patents

Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler

Info

Publication number
NO963254D0
NO963254D0 NO963254A NO963254A NO963254D0 NO 963254 D0 NO963254 D0 NO 963254D0 NO 963254 A NO963254 A NO 963254A NO 963254 A NO963254 A NO 963254A NO 963254 D0 NO963254 D0 NO 963254D0
Authority
NO
Norway
Prior art keywords
pct
hiv
macrocyclic
useful
antivirals
Prior art date
Application number
NO963254A
Other languages
English (en)
Norwegian (no)
Other versions
NO963254L (no
Inventor
Robert Allan Farr
Brent Ludvick Podlogar
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO963254L publication Critical patent/NO963254L/no
Publication of NO963254D0 publication Critical patent/NO963254D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO963254A 1994-02-04 1996-08-02 Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler NO963254D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19208094A 1994-02-04 1994-02-04
PCT/US1994/013711 WO1995021186A1 (en) 1994-02-04 1994-11-28 Macrocyclic difluorostatone derivatives useful as antiviral agents

Publications (2)

Publication Number Publication Date
NO963254L NO963254L (no) 1996-08-02
NO963254D0 true NO963254D0 (no) 1996-08-02

Family

ID=22708156

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963254A NO963254D0 (no) 1994-02-04 1996-08-02 Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler

Country Status (20)

Country Link
US (1) US5969132A (zh)
EP (1) EP0742791B1 (zh)
JP (1) JP3574455B2 (zh)
KR (1) KR100367379B1 (zh)
CN (1) CN1142830A (zh)
AT (1) ATE198602T1 (zh)
AU (1) AU684875B2 (zh)
CA (1) CA2182476C (zh)
DE (1) DE69426574T2 (zh)
DK (1) DK0742791T3 (zh)
ES (1) ES2155515T3 (zh)
FI (1) FI963073A0 (zh)
GR (1) GR3035623T3 (zh)
HU (1) HUT74384A (zh)
IL (1) IL112514A0 (zh)
NO (1) NO963254D0 (zh)
NZ (1) NZ277410A (zh)
PT (1) PT742791E (zh)
WO (1) WO1995021186A1 (zh)
ZA (1) ZA95756B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521420B2 (en) 2003-06-18 2009-04-21 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672792A5 (zh) * 1985-02-19 1989-12-29 Sandoz Ag
WO1986006379A1 (en) * 1985-04-19 1986-11-06 The Upjohn Company Dihalo-statine substituted renin inhibitors
AU3964489A (en) * 1988-07-08 1990-02-05 Smithkline Beckman Corporation Retroviral protease binding peptides
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
ATE143025T1 (de) * 1991-01-02 1996-10-15 Merrell Pharma Inc Antivirale verbindungen
CA2195125C (en) * 1994-07-15 2003-12-16 Robert A. Farr Difluorostatone antiviral agents

Also Published As

Publication number Publication date
ZA95756B (en) 1995-10-05
ATE198602T1 (de) 2001-01-15
ES2155515T3 (es) 2001-05-16
CN1142830A (zh) 1997-02-12
GR3035623T3 (en) 2001-06-29
WO1995021186A1 (en) 1995-08-10
US5969132A (en) 1999-10-19
EP0742791A1 (en) 1996-11-20
NO963254L (no) 1996-08-02
DE69426574D1 (de) 2001-02-15
AU1262295A (en) 1995-08-21
CA2182476C (en) 2000-12-26
DK0742791T3 (da) 2001-04-02
DE69426574T2 (de) 2001-08-09
KR100367379B1 (ko) 2003-04-11
NZ277410A (en) 1997-02-24
FI963073A (fi) 1996-08-02
EP0742791B1 (en) 2001-01-10
JP3574455B2 (ja) 2004-10-06
JPH09508417A (ja) 1997-08-26
FI963073A0 (fi) 1996-08-02
IL112514A0 (en) 1995-05-26
HUT74384A (en) 1996-12-30
AU684875B2 (en) 1998-01-08
HU9602158D0 (en) 1996-09-30
PT742791E (pt) 2001-06-29

Similar Documents

Publication Publication Date Title
ES2139195T3 (es) Derivados de sulfonamidas como inhibidores de la aspartil-proteasa.
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
CY1107626T1 (el) Παραγωγα πυραζολιου για την θεραπεια του hiv
NO20075810L (no) Aminosyrehydroksyetylaminosulfonamid retrovirale proteaseinhibitorer
NZ306026A (en) N-[2-hydroxy-3-sulphonyl-amino]-3-(hydrocarbylsulphonyl)hydrocarbyl-amide derivatives
ATE229945T1 (de) Zur behandlung von cmv infektionen geeignete 1,3, 4-thiadiazole
LV12719A (lv) Benzoxazinones as inhibitors of hiv reverse transcriptase
BR9607625A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
MX9700414A (es) Agentes antivirales de difluoroestatona.
FI911875A (fi) Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen.
NO963254L (no) Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
BR0213741A (pt) composto e composição antiretrovirais

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application